In vitro study on activating autophagy pathway of SHG-44 glioma cells by MG-132

Peng-fei GE,Tian-hao YU,Shuang-lin FU,Hai-feng WANG,Da-wei CHEN,Bin QI,Yi-nan LUO
DOI: https://doi.org/10.3321/j.issn:1001-2346.2008.11.011
2008-01-01
Abstract:Objective To investigate the phenomenon of activating cellular autophagy pathway in glioma SHG-44 cells by dysfuctioning proteasome. Method 5.0μmol/L proteasome specific inhibitor MG-132 was used to inhibit proteasome activity in the SHG-44 glioma cells. HE staining and light microscopy was used to observe cellular alterations in morphology. OA staining and fluorescence microscopy was used to observe the formation of acidic vacuolar organelle. Transmission electronic microscopy was used to observe the subcellular alterations in morphology. Differential centrifuge and western blotting were used to examine the expressional alterations of autophagy-related protein in different cellular fractions. Results After the proteasome activity was inhibited, HE staining and light microscopy showed the nucleus presented deep blue and multi figures with light condensed chromatin and without changes in size, many vacuoles formed in the cytosol and the cytosol around nucleus became acidophilic red. AO staining and fluorescence microscopy showed the nucleus became green and the cytosol around the nucleus became red. Transmission Electronic microscopy showed autophagosome and autophagolysosome presented in the cytosol in the experimental group. Western blotting analysis revealed significantly increased expression of Beclin, LC3-Ⅰ and LC3-Ⅱ in the cells of experimental group. Conclusions Inhibiting proteasome activity could effectively activate autophagy pathway in the glioma SHG-44 cells.
What problem does this paper attempt to address?